Physician profile
Barry G Munn
NPI 1609882034
$1,718.35
in general payments reported to CMS, 2019-2025
28 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $233 · 2021: $345 · 2022: $442 · 2023: $180 · 2024: $147 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $278.01 | 2019-2025 | Orthovisc |
| Stryker Corporation | $266.57 | 2020-2023 | Triathlon |
| Zimmer Biomet Holdings, INC. | $209.34 | 2019-2022 | |
| Smith+Nephew, INC. | $165.44 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Dynasplint Systems INC. | $106.79 | 2021 | |
| Medacta USA, INC. | $106.01 | 2019-2024 | |
| Radius Health, INC. | $100.00 | 2021-2024 | Tymlos |
| Pacira Therapeutics, INC. | $59.30 | 2021 | |
| Amarin Pharma, INC. | $46.01 | 2020 | |
| Lilly USA, LLC | $30.86 | 2020 | |
| Bioventus LLC | $30.57 | 2024 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $29.43 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $28.03 | 2020-2022 | |
| Forte Bio-Pharma LLC | $26.66 | 2021-2022 | |
| Moximed, INC | $25.70 | 2024 | Misha Knee System, Small, Left |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $23.59 | 2024 | Bexsero, Menveo, Pediarix |
| Avanos Medical | $23.31 | 2023 | Trivisc Sodium Hyaluronate |
| Vericel Corporation | $20.05 | 2023 | Maci |
| Daiichi Sankyo INC. | $19.78 | 2020 | |
| Akcea Therapeutics, INC. | $18.76 | 2019 | |
| Heron Therapeutics, INC. | $18.32 | 2021 | |
| Fidia Pharma USA INC. | $17.81 | 2019 | |
| Aroa Biosurgery Incorporated | $14.63 | 2024 | |
| Kci USA, INC. | $14.20 | 2019 | |
| Paragon 28, INC. | $13.19 | 2023 | Ankle Fracture |
| Horizon Therapeutics Plc | $12.37 | 2019 | |
| Reprise Biomedical, INC. | $10.25 | 2021 | |
| Orthofix Medical, INC. | $3.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Munn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.